Shina Systems, a cardiovascular imaging and analysis software services company, will showcase its new product AngioCt at the Transcatheter Cardiovascular Therapeutic (TCT) conference and exposition in Washington, D.C., Oct. 22-24.

"Co-registered with angiography, CTA can be used for determination of stent size and location, optimal C-arm orientation for minimizing foreshortening and vessel masking, and can provide a reference vessel path in cases of CTOs," said Naor Shina, president and CEO of the Israel-based Shina.

Currently, AngioCT is CE approved, and its FDA 510(k) clearance is pending.